Literature DB >> 24293278

Hepcidin production in response to iron is controlled by monocyte-derived humoral factors.

Yusuke Sasaki1, Yasushi Shimonaka, Katsuya Ikuta, Takaaki Hosoki, Katsunori Sasaki, Yoshihiro Torimoto, Hirotaka Kanada, Yoshiyuki Moriguchi, Yutaka Kohgo.   

Abstract

Hepcidin, which is mainly produced by the liver, is the key regulator in iron homeostasis. Hepcidin expression is up-regulated by iron loading in vivo, but the mechanism underlying this process is not completely understood. In the present study, we investigated the mechanism, following the hypothesis that hepcidin production in response to iron loading is regulated by extra-hepatic iron sensors. We measured serum hepcidin concentrations and iron indices in Wistar rats treated with saccharated ferric oxide (SFO). Human hepatoma-derived HepG2 cells were stimulated using SFO-administered rat sera, and co-cultured with rat spleen cells, human monocyte-derived THP-1 cells, or human monocytes with diferric transferrin (holo-Tf), and hepcidin concentrations in the conditioned media were measured. SFO elevated rat serum hepcidin concentrations. SFO-treated rat sera increased hepcidin production from HepG2 cells, and this induction correlated with serum hepcidin levels, but not with iron indices. Holo-Tf up-regulated hepcidin concentrations in media from HepG2 cells co-cultured with rat spleen cells, THP-1 cells, or human monocytes with or without cell-to-cell contacts, while holo-Tf did not up-regulate hepcidin from HepG2 cells alone. Our results suggest the existence of humoral factors capable of inducing hepcidin production that are secreted by extra-hepatic cells, such as reticuloendothelial monocytes, in response to iron.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24293278     DOI: 10.1007/s12185-013-1476-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  47 in total

1.  Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.

Authors:  Paul Robach; Stefania Recalcati; Domenico Girelli; Cecilia Gelfi; Niels J Aachmann-Andersen; Jonas J Thomsen; Anne M Norgaard; Alessandra Alberghini; Natascia Campostrini; Annalisa Castagna; Agnese Viganò; Paolo Santambrogio; Tibor Kempf; Kai C Wollert; Stéphane Moutereau; Carsten Lundby; Gaetano Cairo
Journal:  Blood       Date:  2009-03-04       Impact factor: 22.113

2.  Improved quantification for non-transferrin-bound iron measurement using high-performance liquid chromatography by reducing iron contamination.

Authors:  Katsunori Sasaki; Katsuya Ikuta; Hiroki Tanaka; Takaaki Ohtake; Yoshihiro Torimoto; Mikihiro Fujiya; Yutaka Kohgo
Journal:  Mol Med Rep       Date:  2011-06-27       Impact factor: 2.952

Review 3.  Hepcidin: clinical utility as a diagnostic tool and therapeutic target.

Authors:  Daniel W Coyne
Journal:  Kidney Int       Date:  2011-06-15       Impact factor: 10.612

4.  Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice.

Authors:  Yusuke Sasaki; Mariko Noguchi-Sasaki; Hideyuki Yasuno; Keigo Yorozu; Yasushi Shimonaka
Journal:  Int J Hematol       Date:  2012-11-16       Impact factor: 2.490

5.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

Authors:  Elizabeta Nemeth; Erika V Valore; Mary Territo; Gary Schiller; Alan Lichtenstein; Tomas Ganz
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

6.  Regulation of hepcidin transcription by interleukin-1 and interleukin-6.

Authors:  Pauline Lee; Hongfan Peng; Terri Gelbart; Lei Wang; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

Review 7.  Iron-sensing proteins that regulate hepcidin and enteric iron absorption.

Authors:  Mitchell D Knutson
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

8.  Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up.

Authors:  Naoaki Murao; Masaki Ishigai; Hideyuki Yasuno; Yasushi Shimonaka; Yoshinori Aso
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

9.  Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA.

Authors:  M Fahmy; S P Young
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

10.  Identification of splenic reservoir monocytes and their deployment to inflammatory sites.

Authors:  Filip K Swirski; Matthias Nahrendorf; Martin Etzrodt; Moritz Wildgruber; Virna Cortez-Retamozo; Peter Panizzi; Jose-Luiz Figueiredo; Rainer H Kohler; Aleksey Chudnovskiy; Peter Waterman; Elena Aikawa; Thorsten R Mempel; Peter Libby; Ralph Weissleder; Mikael J Pittet
Journal:  Science       Date:  2009-07-31       Impact factor: 47.728

View more
  4 in total

1.  The three isoforms of hepcidin in human serum and their processing determined by liquid chromatography-tandem mass spectrometry (LC-tandem MS).

Authors:  Lynda Addo; Katsuya Ikuta; Hiroki Tanaka; Yasumichi Toki; Mayumi Hatayama; Masayo Yamamoto; Satoshi Ito; Motohiro Shindo; Yusuke Sasaki; Yasushi Shimonaka; Mikihiro Fujiya; Yutaka Kohgo
Journal:  Int J Hematol       Date:  2016-01       Impact factor: 2.490

2.  In vivo behavior of NTBI revealed by automated quantification system.

Authors:  Satoshi Ito; Katsuya Ikuta; Daisuke Kato; Addo Lynda; Kotoe Shibusa; Noriyasu Niizeki; Yasumichi Toki; Mayumi Hatayama; Masayo Yamamoto; Motohiro Shindo; Naomi Iizuka; Yutaka Kohgo; Mikihiro Fujiya
Journal:  Int J Hematol       Date:  2016-04-16       Impact factor: 2.490

Review 3.  Hepcidin: regulation of the master iron regulator.

Authors:  Gautam Rishi; Daniel F Wallace; V Nathan Subramaniam
Journal:  Biosci Rep       Date:  2015-03-31       Impact factor: 3.840

4.  Hepcidin promotes osteogenic differentiation through the bone morphogenetic protein 2/small mothers against decapentaplegic and mitogen-activated protein kinase/P38 signaling pathways in mesenchymal stem cells.

Authors:  Huading Lu; Liyi Lian; Dehai Shi; Huiqing Zhao; Yuhu Dai
Journal:  Mol Med Rep       Date:  2014-10-24       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.